Health outcomes of age at menarche in European women: a two-sample Mendelian randomization study
Postgraduate Medical Journal · 2023
DOI: 10.1093/postmj/qgad023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Postgraduate Medical Journal, 2023. Verfasst von Yang Lv und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Intensive Care Unit, Wuhan Asia General Hospital, Wuhan, Hubei, 430056, China. Hauptthemen laut MEDLINE: Endometriosis, Eclampsia, Pre-Eclampsia, Breast Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Observational studies have shown an association between age at menarche (AAM) and the risk of gynecological diseases. However, the causality cannot be determined due to residual confounding.
Methods
We conducted a Mendelian randomization (MR) study to evaluate the causal effect of AAM on several gynecological diseases, including endometriosis, female infertility, pre-eclampsia or eclampsia, uterine fibroids, breast cancer, ovarian cancer, and endometrial cancer. Single nucleotide polymorphisms were used as genetic instruments. The inverse variance weighted method was used as the primary approach and several other MR models were conducted for comparison. Cochran’s Q test, Egger’s intercept test, and leave-one-out analysis were conducted for sensitivity analysis. Radial MR analysis was conducted when detecting the existence of heterogeneity.
Results
After Bonferroni correction and thorough sensitivity analysis, we observed a robust causal effect of AAM on endometrial cancer (odds ratio: 0.80; 95% confidence interval: 0.72–0.89; P = 4.61 × 10−5) and breast cancer (odds ratio: 0.94; 95% confidence interval: 0.90–0.98; P = .003). Sensitivity analysis found little evidence of horizontal pleiotropy. The inverse variance weighted method also detected weak evidence of associations of AAM with endometriosis and pre-eclampsia or eclampsia.
Conclusions
This MR study demonstrated a causal effect of AAM on gynecological diseases, especially for breast cancer and endometrial cancer, which indicates AAM might be a promising index to use for disease screening and prevention in clinical practice. Key messages What is already known on this topic – Observational studies have reported associations between age at menarche (AAM) and a variety of gynecological diseases but the causality has not been determined. What this study adds – This Mendelian randomization study demonstrated that AAM causally affects the risk of breast cancer and endometrial cancer. How this study might affect research, practice, or policy – The findings of our study imply that AAM could be a candidate marker for early screening of populations at higher risk of breast cancer and endometrial cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Intensive Care Unit, Wuhan Asia General Hospital, Wuhan, Hubei, 430056, China.
- Department of Medical Intensive Care Unit, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430070, China.
- Intensive Care Unit, Jianli People's Hospital, Jingzhou, Hubei, 433399, China.
Zitieren
APA
Lv, Y., Xia, X., Lei, L., Xiang, W., Wu, X., Xie, S., & Li, J. (2023). Health outcomes of age at menarche in European women: a two-sample Mendelian randomization study. Postgraduate Medical Journal. https://doi.org/10.1093/postmj/qgad023
Vancouver
Lv Y, Xia X, Lei L, Xiang W, Wu X, Xie S, et al. Health outcomes of age at menarche in European women: a two-sample Mendelian randomization study. Postgraduate Medical Journal. 2023. doi:10.1093/postmj/qgad023
BibTeX
@article{Lv2023,
author = {Lv, Yang and Xia, Xing and Lei, Lei and Xiang, Wei and Wu, Xuan and Xie, Songbo and Li, Jie},
title = {Health outcomes of age at menarche in European women: a two-sample Mendelian randomization study},
journal = {Postgraduate Medical Journal},
year = {2023},
doi = {10.1093/postmj/qgad023}
}
EUVIMED